International Endeavors Corporation (OTCMKTS:IDVV) Stock In Focus After Announcing Artificial Intelligence (AI) Client In Medical Sector

International Endeavors Corporation (OTCMKTS:IDVV) on May 5, 2023, announced that AI division WITech has done an agreement with the first client in Medical Sector, Anti Aging & Wellness. The company, Anti Aging & Wellness provides several anti-aging treatments including HGH Therapy, Stem Cell Therapy,and TRT Therapy amongst others.

Trading Data

On Friday, IDVV stock ended flat at $0.0011 with 10.46 million shares, compared to volume of 6.68 million shares. The stock moved within a range of $0.0010 – 0.0013 after opening trade at $0.0011.

IDVV Announces Artificial Intelligence (AI) Client In Medical Sector

Some of the terms of the agreement include extensive AI marketing starting in Nevada, Southern California, and Latin America including Mexico. It will also include developing an AI platform for new patient intake as well as management. This agreement will be for a year non-exclusive as IDVV aims at the expansion of services to other clients in the medical sector.

Lastly, the payment for the agreement will be on a quarterly basis based on specific monthly fees and sales volume.

Vice President Bill Martin said that the firm is pleased on announcing the first agreement in the sector. Martin added that Anti-aging is a booming industry and the company is anticipating yearly revenues to reach a seven-figure range from this agreement.

Martin further said that this is just the start, and the firm will get a steady deal flow for its AI division. He also said that the company’s capabilities on AI was spreading quickly and getting positive feedback from major institutions. The Vice President believes that the company is ready to harness this and grow.